In a pandemic milestone, the NIH ends guidance on COVID treatment
The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.
When the antiviral drug Paxlovid was approved by the Food and Drug Administration in late 2021, many experts hailed it as a game-changing treatment for high-risk patients battling COVID-19.
North Carolina Gov. Roy Cooper said Monday that he has tested positive for COVID-19 but is continuing to work from home while experiencing mild symptoms.